Hims & Hers Health Price to Free Cash Flow Ratio 2020-2023 | HIMS
Historical price to free cash flow ratio values for Hims & Hers Health (HIMS) since 2020.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Hims & Hers Health Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2024-05-02 | 12.24 | 45.54 | |
| 2023-12-31 | 8.90 | $0.27 | 33.11 |
| 2023-09-30 | 6.29 | $0.16 | 38.33 |
| 2023-06-30 | 9.40 | $0.09 | 109.94 |
| 2023-03-31 | 9.92 | $-0.00 | 0.00 |
| 2022-12-31 | 6.41 | $-0.14 | 0.00 |
| 2022-09-30 | 5.58 | $-0.13 | 0.00 |
| 2022-06-30 | 4.53 | $-0.24 | 0.00 |
| 2022-03-31 | 5.33 | $-0.18 | 0.00 |
| 2021-12-31 | 6.55 | $-0.19 | 0.00 |
| 2021-09-30 | 7.54 | $-0.18 | 0.00 |
| 2021-06-30 | 10.89 | $-0.03 | 0.00 |
| 2021-03-31 | 13.23 | $-0.07 | 0.00 |
| 2020-12-31 | 14.60 | $-0.12 | 0.00 |
| 2020-09-30 | 11.75 | $-0.06 | 0.00 |
| 2020-06-30 | 10.17 | $-0.17 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.680B | $0.872B |
| Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $35.723B | 19.61 |
| Inspire Medical Systems (INSP) | United States | $7.393B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.477B | 0.00 |
| Axonics (AXNX) | United States | $3.412B | 0.00 |
| 10x Genomics (TXG) | United States | $3.208B | 0.00 |
| Enovis (ENOV) | United States | $3.038B | 23.08 |
| Azenta (AZTA) | United States | $2.905B | 236.82 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.820B | 0.00 |
| Privia Health (PRVA) | United States | $2.139B | 94.89 |
| Schrodinger (SDGR) | United States | $1.827B | 0.00 |
| Omnicell (OMCL) | United States | $1.248B | 30.53 |
| Phreesia (PHR) | United States | $1.185B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.821B | 0.00 |
| Standard BioTools (LAB) | United States | $0.737B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.680B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.619B | 0.00 |
| Talkspace (TALK) | United States | $0.536B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.373B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.329B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.318B | 0.00 |
| Pulmonx (LUNG) | United States | $0.298B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.183B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.164B | 0.00 |
| American Well (AMWL) | United States | $0.154B | 0.00 |
| Outset Medical (OM) | United States | $0.147B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.129B | 0.00 |
| Augmedix (AUGX) | United States | $0.124B | 0.00 |
| TruBridge (TBRG) | United States | $0.118B | 5.04 |
| 111 (YI) | China | $0.088B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.068B | 0.00 |
| HeartBeam (BEAT) | United States | $0.057B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| Movano (MOVE) | United States | $0.048B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.046B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.033B | 0.00 |
| Akili (AKLI) | United States | $0.031B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.025B | 0.00 |
| Cue Health (HLTH) | United States | $0.021B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
| CareCloud (CCLD) | United States | $0.018B | 0.00 |
| ETAO (ETAO) | United States | $0.016B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
| Biotricity (BTCY) | United States | $0.013B | 0.00 |
| Transgenomic (PRPO) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |